ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FGEN FibroGen Inc

1.04
-0.02 (-1.89%)
Last Updated: 13:27:06
Delayed by 15 minutes

Period:

Draw Mode:

Volume 661,005
Bid Price 1.03
Ask Price 1.04
News (1)
Day High 1.08

Low
0.3333

52 Week Range

High
17.46

Day Low 1.03
Share Name Share Symbol Market Stock Type
FibroGen Inc FGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.02 -1.89% 1.04 13:27:06
Open Price Low Price High Price Close Price Previous Close
1.08 1.03 1.08 1.06
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,909 661,005 US$ 1.05 US$ 694,793 - 0.3333 - 17.46
Last Trade Type Quantity Price Currency
13:27:06 100 US$ 1.04 USD

FibroGen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
101.73M 98.77M - 147.75M -284.23M -2.88 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

FibroGen News

Date Time Source News Article
6/18/202407:00GlobeNewswire Inc.FibroGen to Host Part II of Virtual KOL Investor Event..
6/13/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/10/202417:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202418:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202418:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202415:12Edgar (US Regulatory)Form 8-K - Current report
6/06/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No FGEN Message Board. Create One! See More Posts on FGEN Message Board See More Message Board Posts

Historical FGEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.121.201.031.131,030,405-0.08-7.14%
1 Month1.211.4751.031.192,226,758-0.17-14.05%
3 Months2.672.790.901051.332,423,338-1.63-61.05%
6 Months0.682.930.56691.562,521,6050.3652.94%
1 Year16.6417.460.33331.583,140,780-15.60-93.75%
3 Years25.8230.12490.33336.791,714,341-24.78-95.97%
5 Years43.1257.20880.333314.011,345,953-42.08-97.59%

FibroGen Description

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Your Recent History

Delayed Upgrade Clock